Researchers demonstrate methods to improve variant classification in genes, suggesting new pathogenic mechanisms.
By following these steps, researchers can maximize the value of MAVEs, strengthen the functional evidence for clinical variant classification, reclassify more VUS, and potentially uncover novel mechanisms of pathogenicity for clinically relevant genes.
No takes yet. Share an insight, caveat, or question.
Jeffrey D Calhoun (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: